This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
SGD Pharma, a distributor in pharmaceutical glass primary packaging solutions, present its innovative range of products and services, including its platform Sealian, an internal treatment that enhances the performance of molded glass vials.
SGD Pharma’s Sealian platform is an internal treatment for glass vials that creates a barrier coating to preserve the integrity of the sensitive therapeutic product inside, improving chemical durability for alkaline solutions and further reducing any interactions with the packaging. Sealian offers enhanced hydrophobic properties for all pharma applications, preventing high viscosity infusions from sticking to the internal surface of the vial, allowing for perfect transparency and easy inspection, as well as ensuring that every drop of the drug product can be used.
SGD Pharma is one of the few molded glass suppliers to offer a pharmaceutical-grade internal treatment for molded glass vials and the company has invested several million euros into an ISO 15378 certified facility at its Saint-Quentin Lamotte (SQLM) plant in France, to ensure rigorous quality control and guaranteed production output and responsiveness. Sealian is suitable for all routes of administration (parenteral, oral and nasal) and is available for all glass types in vial sizes ranging from 3ml to 500ml in both clear and amber glass.
